SCHEMBL31511202

SCHEMBL31511202

COc1ccc(CSc2c(OC)cc(C3OCCO3)cc2OC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.40
▸ MAOB P27338 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ MAOA P21397 2/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ DAO P14920 1/20 0.37
▸ FABP3 P05413 1/20 0.36
▸ FABP4 P15090 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31511064 0.83 PDE2A (0.41) APPMAOBLMNAMMP13MAOA
SCHEMBL27002019 0.72 ALDH1A1 (0.47) APPMAOBLMNAMMP13MAOA
SCHEMBL31511172 0.71 PDE4B (0.43) LMNAMMP13ALDH1A1MEN1KMT2A
SCHEMBL4723773 0.71 MAOA (0.48) MAOBLMNAMAOANPC1RAB9A
SCHEMBL11101046 0.68 ACHE (0.58) ALDH1A1MEN1KMT2ATUBB4ATUBB
SCHEMBL7814854 0.68 NPC1 (0.43) ALDH1A1MEN1NPC1RAB9AKMT2A
SCHEMBL2200862 0.68 ALDH1A1 (0.48) ALDH1A1NPC1RAB9AKMT2A
SCHEMBL18288113 0.67 ALDH1A1 (0.58) ALDH1A1NPSR1RAB9A
SCHEMBL5783392 0.67 PTPN1 (0.40) ALDH1A1NPSR1MEN1KMT2AMAPT
SCHEMBL8155961 0.67 ESR2 (0.45) MAOBLMNAMAOAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-09-04 — — US disclosed
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-04-17 — — US disclosed
WO-2025074249-A1 NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2025-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 APP 4604/4885MAOB 2843/4885LMNA 2217/4885
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 APP 4589/4885MAOB 2750/4885LMNA 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback